Literature DB >> 25774832

Metabolic pathways promoting cancer cell survival and growth.

Lindsey K Boroughs1, Ralph J DeBerardinis2.   

Abstract

Activation of oncogenes and loss of tumour suppressors promote metabolic reprogramming in cancer, resulting in enhanced nutrient uptake to supply energetic and biosynthetic pathways. However, nutrient limitations within solid tumours may require that malignant cells exhibit metabolic flexibility to sustain growth and survival. Here, we highlight these adaptive mechanisms and also discuss emerging approaches to probe tumour metabolism in vivo and their potential to expand the metabolic repertoire of malignant cells even further.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25774832      PMCID: PMC4939711          DOI: 10.1038/ncb3124

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  103 in total

1.  Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

Authors:  Julian J Lum; Daniel E Bauer; Mei Kong; Marian H Harris; Chi Li; Tullia Lindsten; Craig B Thompson
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

Review 2.  Increased lipogenesis in cancer cells: new players, novel targets.

Authors:  Johannes V Swinnen; Koen Brusselmans; Guido Verhoeven
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-07       Impact factor: 4.294

3.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.

Authors:  Frank Weinberg; Robert Hamanaka; William W Wheaton; Samuel Weinberg; Joy Joseph; Marcos Lopez; Balaraman Kalyanaraman; Gökhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 4.  Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Barbara Chiavarina; Stephanos Pavlides; Diana Whitaker-Menezes; Aristotelis Tsirigos; Agnieszka Witkiewicz; Zhao Lin; Renee Balliet; Anthony Howell; Federica Sotgia
Journal:  Cancer Biol Ther       Date:  2010-09-19       Impact factor: 4.742

5.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

Review 6.  Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Authors:  David A Mankoff; Janet F Eary; Jeanne M Link; Mark Muzi; Joseph G Rajendran; Alexander M Spence; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

7.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

8.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

Authors:  Patrick S Ward; Jay Patel; David R Wise; Omar Abdel-Wahab; Bryson D Bennett; Hilary A Coller; Justin R Cross; Valeria R Fantin; Cyrus V Hedvat; Alexander E Perl; Joshua D Rabinowitz; Martin Carroll; Shinsan M Su; Kim A Sharp; Ross L Levine; Craig B Thompson
Journal:  Cancer Cell       Date:  2010-02-18       Impact factor: 38.585

9.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

10.  Quantitative flux analysis reveals folate-dependent NADPH production.

Authors:  Jing Fan; Jiangbin Ye; Jurre J Kamphorst; Tomer Shlomi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Nature       Date:  2014-05-04       Impact factor: 49.962

View more
  499 in total

Review 1.  Transcriptional regulation of T cell metabolism.

Authors:  Kenneth P Hough; Danielle A Chisolm; Amy S Weinmann
Journal:  Mol Immunol       Date:  2015-08-19       Impact factor: 4.407

2.  TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions.

Authors:  Inmaculada Martínez-Reyes; Lauren P Diebold; Hyewon Kong; Michael Schieber; He Huang; Christopher T Hensley; Manan M Mehta; Tianyuan Wang; Janine H Santos; Richard Woychik; Eric Dufour; Johannes N Spelbrink; Samuel E Weinberg; Yingming Zhao; Ralph J DeBerardinis; Navdeep S Chandel
Journal:  Mol Cell       Date:  2015-12-24       Impact factor: 17.970

3.  Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.

Authors:  M Tandon; Z Chen; A H Othman; J Pratap
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 4.  Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

Authors:  Kristofor A Olson; John C Schell; Jared Rutter
Journal:  Trends Biochem Sci       Date:  2016-02-10       Impact factor: 13.807

5.  Tissue necrosis and its role in cancer progression.

Authors:  Adi Karsch-Bluman; Ariel Feiglin; Eliran Arbib; Tal Stern; Hila Shoval; Ouri Schwob; Michael Berger; Ofra Benny
Journal:  Oncogene       Date:  2018-11-02       Impact factor: 9.867

6.  The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.

Authors:  Yuan Guan; Xinyu Chen; Manhong Wu; Wan Zhu; Ahmed Arslan; Saori Takeda; Mindie H Nguyen; Ravindra Majeti; Dan Thomas; Ming Zheng; Gary Peltz
Journal:  J Hepatol       Date:  2019-11-22       Impact factor: 25.083

Review 7.  Endothelial Metabolic Control of Lymphangiogenesis.

Authors:  Pengchun Yu; Guosheng Wu; Heon-Woo Lee; Michael Simons
Journal:  Bioessays       Date:  2018-05-11       Impact factor: 4.345

Review 8.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

9.  Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.

Authors:  Jin Xiang; Chang Chen; Rui Liu; Dongmei Gou; Lei Chang; Haijun Deng; Qingzhu Gao; Wanjun Zhang; Lin Tuo; Xuanming Pan; Li Liang; Jie Xia; Luyi Huang; Ke Yao; Bohong Wang; Zeping Hu; Ailong Huang; Kai Wang; Ni Tang
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

10.  Role of nucleolar protein NOM1 in pancreatic islet β cell apoptosis in diabetes.

Authors:  Leilei Yu; Huifeng Wang; Zhongxiu Guo; Fenghua Li; Hong Cui
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.